Rybrevant (Amivantamab-Vmjw) Drug Interactions: 1 Moderate
Rybrevant (Amivantamab-Vmjw) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Rybrevant. Always confirm against the full prescribing information.
100 interactions
Adalimumab
The risk or severity of adverse effects can be increased when Adalimumab is combined with Amivantamab.
Level 2 evidence
Aducanumab
The risk or severity of adverse effects can be increased when Aducanumab is combined with Amivantamab.
Level 2 evidence
Alemtuzumab
The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Amivantamab.
Level 2 evidence
Alirocumab
The risk or severity of adverse effects can be increased when Alirocumab is combined with Amivantamab.
Level 2 evidence
Anifrolumab
The risk or severity of adverse effects can be increased when Anifrolumab is combined with Amivantamab.
Level 2 evidence
Ansuvimab
The risk or severity of adverse effects can be increased when Ansuvimab is combined with Amivantamab.
Level 2 evidence
Anthrax immune globulin human
The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Amivantamab.
Level 2 evidence
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Amivantamab.
Level 2 evidence
Antithymocyte immunoglobulin (rabbit)
The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Amivantamab.
Level 2 evidence
Asfotase alfa
The risk or severity of adverse effects can be increased when Asfotase alfa is combined with Amivantamab.
Level 2 evidence
Atezolizumab
The risk or severity of adverse effects can be increased when Atezolizumab is combined with Amivantamab.
Level 2 evidence
Atoltivimab
The risk or severity of adverse effects can be increased when Atoltivimab is combined with Amivantamab.
Rybrevant (Amivantamab-Vmjw) has 163 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Rybrevant (Amivantamab-Vmjw) has 0 major, 1 moderate, and 162 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Rybrevant. Always confirm against the full prescribing information.